Directing program strategies to drive value for every stakeholder:Integrated drug development strategies -Lead the development and execution of programs that advance the value of cardiovascular and oncology products for patients, providers, and payers.-Develop and implement business strategies to maximise the value of cardiovascular and oncology assets Functional experience-Identify and implement strategies to expand the clinical use of in-market assets, such as through new indications, patient populations, or delivery methods.-Build data strategies to gain insights into patient needs and preferences, and to identify opportunities to improve therapies.People leadership -Foster collaboration across global teams to leverage expertise and resources, and to ensure that all stakeholders are aligned on priorities and goals.Entrepreneurial spirit -Streamline complex business interfaces, resulting in a smooth transition of drug development projects-Taking a proactive approach to risk management by identifying and assessing potential risks early on, and then implementing tangible mitigation strategies to reduce or eliminate those risks.

Business strategies -Developed and executed strong business plans that helped make objective decisions for drug development projects, from early development to late life cycle management.Collaboration for common outcome-Worked with cross-functional and cross-divisional teams from around the world to develop and execute strategies for drug and non-drug development projects.Risk management -Managed risks and issues proactively and reactively related to development and in-market assets.

Asset transitions -Led the successful transition and operationalisation of the Hypertension and Diabetes global program teams.Process and system management -Developed and maintained systems that could dynamically update project milestones from various systems, as required by stakeholders.

Project-Program management-Developed and maintained accurate and realistic drug development project plans that reflect prioritisation and approved strategy.-Managed key milestones by collaborating and communicating effectively with relevant stakeholders.-Provided integrated project plans, regular program status, and budget updates.-Identified risk areas in the process and implement controls to mitigate them.Operations management -Handled multiple projects and ensure timely completion of tasks.

Overall management of research product portfolios-Overseen the development and commercialisation of research product portfolios.-Ensured that product portfolios meet the needs of out-licensing, regulatory, and marketing stakeholders.-Provided strategic input for target prioritization and therapeutic modality selection.-Identified opportunities to optimize anti-infective and oncology research product pipelines.-Provided technical support to teams responsible for developing and commercializing products.Functional leadership -Developed and guided a team of scientists responsible for conducting in-vitro PK/PD modelling studies and population PK studies.-Provided scientific support to clinical research, drug regulatory affairs, and product management teams.-Developed a multidisciplinary team for health economics and outcomes research.

Project Management-Handled multiple projects (oncology, cardiovascular, and ophthalmic) and ensured timely turnover of medical writing deliverables.Training and development -Trained team members with particular emphasis on therapeutic areas, statistics, and regulatory requirements (USFDA, EU guidelines) for medical writing deliverables.Process and system management -Developed general and project specific medical writing SOPs and placed quality control systems for SOP compliance across the medical writing team.Functional experience -Reviewed prepared clinical study protocols, investigator brochures, clinical study reports, web-synopsis, risk management plans, ICSRs, and PSURs.

Team management-Led a group of medical writers to deliver multiple projects within the expected timeframe for MNC clients.Process compliance -Maintained SOPs, working guidelines, and training modules.Quality management -Devised new methods of checks and balances to improve the overall quality of deliverables.

Functional experience -Preparation and review of Clinical Study Protocols, Clinical Study Reports, Web-Synopsis, Safety Narratives for USFDA submissions.Training and development -Trained team members on clinical trial related topics with emphasis on methodological and statistical issues.Process compliance-Established SOPs, working guidelines, and training modules for medical writing line function.

Preclinical studies-Created rodent models of neuropsychiatric diseases and validated them using face, construct, and predictive validity.-Rodents models were used to establish quantitative associations of GRK3 with stress resilience and stress susceptibility.Data analytics-Developed statistical models to predict behavioral changes in rodents based on changes in proteins of interest.-Analysed and interpreted multivariate data using SAS to identify temporal and spatial biochemical changes in the brain that can be used as diagnostic markers for stress-induced neuropsychiatric illnesses.Scientific communications-Prepared manuscripts for publication in peer-reviewed scientific journals related to clinical and preclinical research.-Presented research findings at international conferences in a scientifically creative format for a multi-disciplinary audience.-Actively participated in writing scientific grants to identify new targets for neuropsychiatric/cardiovascular diseases and their better therapeutic interventions.

Training and development -Instructed laboratory sessions for undergraduate level courses (medicinal chemistry, cell and molecular biology).-Supported the preparation of lecture content, grading of assignments, and provided feedback to students.-Facilitated classroom discussions and held office hours to meet with students and answer questions about course material.-Maintained course materials on the "central platform" and ensured that students had access to the resources they needed to succeed in the course work.

Bio analysis & PK -Developed and validated methods for quantifying drugs using LC-MS/MS (API-3000 and 4000 / APCI) and HPLC as per USFDA and ANVISA guidelines.-Generated, recorded, and documented data according to GLP/GCP requirements.-Analysed and interpreted data based on the drug's pharmacokinetic parameters.

Pharmaceutical analytical testing -Conducted analytical testing of raw materials, in-process products, and finished products in accordance with the requirements of the Indian Pharmacopoeia (IP), United States Pharmacopeia (USP), and British Pharmacopoeia (BP).-Generated analytical testing reports in accordance with Good Laboratory Practice (GLP) requirements.